Market Overview:
The global in-vitro toxicology/toxicity testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for in-vitro toxicology/toxicity testing services from the pharmaceutical, chemical, and food industries. In addition, the growing adoption of high throughput technologies and omics technologies is also contributing to the growth of this market. On the basis of type, cell culture technology held the largest share of the global in-vitro toxicology/toxicity testing market in 2017. This segment is expected to grow at a CAGR of 7.8% during 2018–2030 owing to its ability to provide accurate results with minimal variability across different batches or types of cells used for toxicity studies. On the basis application, pharmaceutical industry held majority share (39%)of global in-vitro toxicology/toxicity testing market revenue followed by chemical industry which accounted for 27%.
Product Definition:
In-vitro toxicology is the study of the adverse effects of chemicals on cells or tissues grown in a laboratory dish (in vitro). The toxicity testing of potential drugs and other chemical substances is an important part of drug discovery and development. Toxicity data from in vitro experiments can help researchers to identify compounds that are likely to be safe and effective for use in humans.
Cell Culture Technology:
Cell culture technology is a set of procedures used to grow and study cells in a controlled environment. It helps in the production of cell-based models for drug development, toxicology testing, and other research purposes. The factors that propel the growth factor in in vitro toxicology/toxicity testing market include rising demand for personalized medicines by pharmaceutical companies & government agencies along with growing R&D activities related to drug discovery & development.
High Throughput Technologies:
High Throughput Technologies (HTT) is a set of advanced technologies that are used to perform toxicology testing with higher throughput and in greater numbers. HTT includes automation, computerization, miniaturization, and networking which has led to the development of next-generation toxicology assays. These technologies have enabled scientists to conduct toxicity tests on large scale thereby increasing the overall efficiency by reducing cost associated with conventional techniques.
Application Insights:
The other application segment includes the study of toxicity against non-mammalian species such as insects, plant and fungi. The increasing demand for toxicology testing services by regulatory authorities across the globe is expected to boost growth over the forecast period. In addition, a rise in R&D activities pertaining to new drug development is anticipated to further fuel market growth during the estimated period.
The pharmaceutical industry accounted for a major share owing to extensive usage of animals in preclinical trials and clinical trials throughout various stages of drug discovery & development process. Moreover, this industry utilizes advanced technologies including cell culture techniques and high throughput screening methods that help reduce costs while enhancing predictive power with respect to human health outcomes. This has led regulatory authorities across countries worldwide towards adopting policies that promote alternatives for replacing animal tests with human cell cultures or computer simulation studies when these are available appropriate and reliable enough (i.
Regional Analysis:
North America dominated the global in-vitro toxicology/toxicity testing market with a revenue share of over 35% in 2017. This is due to the presence of well-established healthcare infrastructure, high adoption rate for advanced technologies, and government support for R&D activities. Moreover, increasing demand for pharmaceuticals and chemicals has led to an increase in their production which is further expected to drive regional growth during the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to factors such as developing economy, rising disposable income coupled with growing awareness about early diagnosis among patients leading towards higher penetration of new products and therapies resulting into increased usage rates thus driving demand across various applications within this region.
Growth Factors:
- Increasing demand for In-Vitro Toxicology/ Toxicity Testing from biopharmaceutical and CRO industries to meet the regulatory compliance.
- Rising prevalence of chronic diseases and increasing R&D expenditure by pharmaceutical companies for novel drug discovery are the major factors driving the growth of In-Vitro Toxicology/ Toxicity Testing market.
- Growing number of public and private sector funding for life science research is also fuelling the demand for In-Vitro Toxicology/ Toxicity Testing services.
- Technological advancements in toxicity testing platforms and increasing use of biomarkers are expected to boost the growth of this market in next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
In-Vitro Toxicology/ Toxicity Testing Market Research Report
By Type
Cell Culture Technology, High Throughput Technologies, Molecular Imaging Technologies, Omics Technologies
By Application
Pharmaceutical Industry, Chemical Industry, Food Industry, Other
By Companies
Agilent Technologies, Abbott, Bio-Rad Laboratories, Bioreliance, Catalent, Charles River Laboratories International, Covance, Cyprotex, Eurofins Scientific, GE Healthcare, Life Technologies Corporation, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global In-Vitro Toxicology/ Toxicity Testing Market Report Segments:
The global In-Vitro Toxicology/ Toxicity Testing market is segmented on the basis of:
Types
Cell Culture Technology, High Throughput Technologies, Molecular Imaging Technologies, Omics Technologies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industry, Chemical Industry, Food Industry, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Abbott
- Bio-Rad Laboratories
- Bioreliance
- Catalent
- Charles River Laboratories International
- Covance
- Cyprotex
- Eurofins Scientific
- GE Healthcare
- Life Technologies Corporation
- Quest Diagnostics
Highlights of The In-Vitro Toxicology/ Toxicity Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Culture Technology
- High Throughput Technologies
- Molecular Imaging Technologies
- Omics Technologies
- By Application:
- Pharmaceutical Industry
- Chemical Industry
- Food Industry
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In-Vitro Toxicology/ Toxicity Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In-vitro toxicity testing is a laboratory procedure used to study the toxic effects of chemicals on cells in a controlled environment.
Some of the key players operating in the in-vitro toxicology/ toxicity testing market are Agilent Technologies, Abbott, Bio-Rad Laboratories, Bioreliance, Catalent, Charles River Laboratories International, Covance, Cyprotex, Eurofins Scientific, GE Healthcare, Life Technologies Corporation, Quest Diagnostics.
The in-vitro toxicology/ toxicity testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In-Vitro Toxicology/ Toxicity Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In-Vitro Toxicology/ Toxicity Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In-Vitro Toxicology/ Toxicity Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In-Vitro Toxicology/ Toxicity Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In-Vitro Toxicology/ Toxicity Testing Market Size & Forecast, 2020-2028
4.5.1 In-Vitro Toxicology/ Toxicity Testing Market Size and Y-o-Y Growth
4.5.2 In-Vitro Toxicology/ Toxicity Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cell Culture Technology
5.2.2 High Throughput Technologies
5.2.3 Molecular Imaging Technologies
5.2.4 Omics Technologies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical Industry
6.2.2 Chemical Industry
6.2.3 Food Industry
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In-Vitro Toxicology/ Toxicity Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In-Vitro Toxicology/ Toxicity Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cell Culture Technology
9.6.2 High Throughput Technologies
9.6.3 Molecular Imaging Technologies
9.6.4 Omics Technologies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical Industry
9.10.2 Chemical Industry
9.10.3 Food Industry
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cell Culture Technology
10.6.2 High Throughput Technologies
10.6.3 Molecular Imaging Technologies
10.6.4 Omics Technologies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical Industry
10.10.2 Chemical Industry
10.10.3 Food Industry
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cell Culture Technology
11.6.2 High Throughput Technologies
11.6.3 Molecular Imaging Technologies
11.6.4 Omics Technologies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical Industry
11.10.2 Chemical Industry
11.10.3 Food Industry
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cell Culture Technology
12.6.2 High Throughput Technologies
12.6.3 Molecular Imaging Technologies
12.6.4 Omics Technologies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical Industry
12.10.2 Chemical Industry
12.10.3 Food Industry
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cell Culture Technology
13.6.2 High Throughput Technologies
13.6.3 Molecular Imaging Technologies
13.6.4 Omics Technologies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical Industry
13.10.2 Chemical Industry
13.10.3 Food Industry
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In-Vitro Toxicology/ Toxicity Testing Market: Competitive Dashboard
14.2 Global In-Vitro Toxicology/ Toxicity Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agilent Technologies
14.3.2 Abbott
14.3.3 Bio-Rad Laboratories
14.3.4 Bioreliance
14.3.5 Catalent
14.3.6 Charles River Laboratories International
14.3.7 Covance
14.3.8 Cyprotex
14.3.9 Eurofins Scientific
14.3.10 GE Healthcare
14.3.11 Life Technologies Corporation
14.3.12 Quest Diagnostics
